No Data
No Data
No Data
No Data
No Data
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
DURHAM, N.C., April 24, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients
ChimerixApr 24 00:00 ET
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DURHAM, N.C., April 16, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX) today announced that on April 10, 2024, the Compensation Committee of Chimerix's Board of Directors granted inducement awards
ChimerixApr 16 00:00 ET
We Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth Carefully
Yahoo FinanceApr 15 06:17 ET
Express News | WHO's Tedros Adhanom Ghebreyesus Posts On X "In #DRC Alone, More Than 4500 Cases of #mpox and Almost 300 Deaths Have Been Reported This Year. That Is Triple the Number Reported at This Time Last Year. The Recent Surge in Cases and Deaths Among Children Is
Moomoo 24/7Apr 11 10:09 ET
Chimerix Board Changes: Machado Resigns, Kozin Appointed
TipRanksMar 21 08:42 ET
Press Release: Chimerix Appoints Marc D. Kozin to Board of Directors
Chimerix Appoints Marc D. Kozin to Board of Directors Veteran Industry Executive Brings More Than 35 Years of Corporate Strategy Experience DURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix
Dow JonesMar 21 07:00 ET
No Data
No Data